Analysed CELULARITY INC-A (CELU:NASDAQ) News Sources
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
21-04-2026
yahoo.com
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
15-04-2026
yahoo.com
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
08-04-2026
yahoo.com
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
31-03-2026
yahoo.com
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
12-03-2026
yahoo.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
12-03-2026
yahoo.com
Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board
12-03-2026
proactiveinvestors.com
What is the current price of CELULARITY INC-A (CELU:NASDAQ)?
The current price of CELULARITY INC-A (CELU:NASDAQ) is $1.22.
CELULARITY INC-A (CELU:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELULARITY INC-A (CELU:NASDAQ) since the previous trading day is $-0.02.
CELULARITY INC-A (CELU:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELULARITY INC-A (CELU:NASDAQ) since the previous trading day is -1.6129%.
What is the most recent average sentiment score for CELULARITY INC-A (CELU:NASDAQ)?
The most recent average sentiment score for CELULARITY INC-A (CELU:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for CELULARITY INC-A (CELU:NASDAQ)?
The most recent sentiment for CELULARITY INC-A (CELU:NASDAQ) is .
SEC-8K** Filing Available For CELULARITY INC-A (CELU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.